Further assessment is needed to understand if these treatment recommendations were eventually adopted and if adoption leads to better outcomes,” researchers wrote.

Consuming a lower-fat diet and taking a fish oil supplement daily reduced the Ki-67 index in patients with prostate cancer on active surveillance.

The FDA has authorized an expanded access program that will allow for the use of a recombinant bacillus Calmette-Guerin product.

Although there was a significant decline in the age-adjusted incidence-based mortality rate from 2006 to 2020, our study did not show a significant improvement in survival outcomes,” the researchers ...

Artificial intelligence systems require consistent monitoring and staffing to put in place and to keep them working well.

The FDA has approved the biologics license applications for Ospomyv and Xbryk, biosimilars to Prolia and Xgeva, respectively.

The Trump Administration’s censorship extends beyond federal websites and datasets to include research to be published in academic journals.

Real-world data suggest that, although guideline-concordant care is on the rise, many US patients with mHSPC may not receive it.

Patients with stage IA HER2+ breast cancer and smaller tumors had high BCSS rates whether they received adjuvant chemotherapy or not.